Efficacy of Non-Acetylcholinesterase Therapies in Cognitive Decline

Name: Efficacy of Non-Acetylcholinesterase Therapies in Cognitive Decline
Brand: LAP LAMBERT Academic Publishing
Availability: OutOfStock
Rating: 5 (1 reviews)

By Iyanuloluwa Ojo

0 - Default Title

Description

Cognitive decline in aging populations, particularly among those diagnosed with mild cognitive impairment (MCI) and Alzheimer's disease (AD), poses an increasing public health challenge. For decades, acetylcholinesterase inhibitors have remained the cornerstone of pharmacologic intervention in these groups. However, growing concerns about their cardiovascular and respiratory adverse effects - especially in elderly patients with multiple comorbidities - necessitate the exploration of alternative therapies with safer profiles and potentially superior efficacy.This work presents the findings of a systematic review and meta-analysis aimed at identifying and evaluating non-acetylcholinesterase treatments for cognitive decline in patients with MCI, AD, or in individuals aged 65 years and above. We conducted a rigorous literature search of PubMed and the Cochrane Library, covering studies published between January 1, 1990, and September 30, 2024. Eligible studies included randomized clinical trials and longitudinal follow-ups that utilized standardized neurological assessments to measure cognitive outcomes.

Product details

Binding:: Paperback
Number of Pages:: 84
Release Date:: 2025-04-24
Publication Date:: 2025-04-24
Publisher:: LAP LAMBERT Academic Publishing
Languages:: Original: English
ISBN10:: 6207808630
ISBN13:: 9786207808632
GPSR Manufacturer Reference:: [email protected]
Weight:: 143 g
Height:: 15 cm
Width:: 22 cm
Thickness:: 0.6 cm

Buy on Amazon

Currently sold out

Add to Wishlist